載入...
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeut...
Na minha lista:
| 發表在: | Eur J Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671267/ https://ncbi.nlm.nih.gov/pubmed/25529558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201445132 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|